Our early-stage research shows that intermittent fasting may slow cancer growth on a cellular level. Our team is recruiting both healthy controls and participants with hematological (blood) cancers who are willing to limit their eating to an 8 hour window per day for 3 or 6 months. We will investigate whether time-restricted eating slows tumour growth, affects cellular process, and improves quality of life.

You will follow 16/8 time-restricted (eating during an 8 hour window) for 6 days per week for a choice of either 3 or 6 months. At the start and end of the study you will complete a quality of life questionnaire and get monthly bloodwork at LifeLabs. You will track your eating times and receive check-ins from a study team member weekly for first month of study and bi-weekly check-ins thereafter to ensure your well-being as safety. There is an option to provide stool samples and completing an end of study interview. Participants without cancer will not complete stool samples or questionnaires and will only complete check-ins for first month of the study.